OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
• Abstract Chimeric antigen receptor (CAR)-natural killer (NK) cell therapies hold promise for solid tumours but remain limited because of poor tumour infiltration, persistence and
• Abstract Chimeric antigen receptor (CAR)-natural killer (NK) cell therapies hold promise for solid tumours but remain limited because of poor tumour infiltration, persistence and
• [Sponsored] Cold and heat therapy remain foundational tools in musculoskeletal care, postoperative recovery and sports rehabilitation. • The post Top-Rated Gel Packs for Physical
• Plants have an immune system, like people, and when it is triggered by threats like disease or pests, a plant’s defenses are activated. • But there’s a downside to this protectiv
• Shalin Shah, CEO of Marius Pharmaceuticals, which makes an oral testosterone replacement drug, thinks TRT therapy should no longer be regulated as a controlled substance The post
• When people hear dosage, they often think of medication. • But dosage is a broader clinical concept. • It is the structure that makes an intervention legible to clinicians, payer
• Illustration of CAR T-cell therapy (green) attacking a cancer cell (pink)NEMES LASZLO/SCIENCE PHOTO LIBRARY Illustration of CAR T-cell therapy (green) attacking a cancer cell (pi
• The gene therapy is administered as a mist that is inhaledNico De Pasquale Photography/Getty Images The gene therapy is administered as a mist that is inhaled Nico De Pasquale Ph
• Official websites use .govA.govwebsite belongs to an official government organization in the United States. • Secure .gov websites use HTTPSAlock(LockA locked padlock) orhttps://